TOP TIERMARKET NEWSWIRE
News & sentiment

OLEMA PHARMACEUTICAL (OLMA) — News & AI sentiment

OLEMA PHARMACEUTICAL (OLMA) news roundup. 3 stories in the past week, 5 over 30 days. Average 30-day sentiment is 52/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 53.3/100
30d stories
5
avg sentiment 52/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

OLMA news in the last 24 hours, 7 days, 30 days and 90 days

How much OLMA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowOLMA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days353.3/100OLMA headlines →
Last 30 days552/100OLMA headlines →
Last 90 days2149.2/100OLMA headlines →

Latest stories on OLMA

4d ago
6d ago
6d ago
Oct 15
Oct 15
Sep 15
Sep 14
Sep 14
Stifel cuts Olema Pharmaceuticals price target on trial concerns
Investing.com Analyst Ratings34 · bearishanalyst
Sep 14
Why is Olema Pharmaceuticals stock sliding today?
Investing.com Markets34 · bearishgeneral
Sep 14
Sep 10
Sep 9
Aug 31
Aug 31
Aug 17
Olema Oncology names Jason O’Byrne as CFO
Seeking Alpha56 · neutralgeneral
Aug 13
Aug 13
Aug 13
Aug 13
Aug 13
Aug 11
Aug 10
Aug 10
Aug 10
Jul 2
Open OLMA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →